UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives

Journal of thrombosis and haemostasis, 2004-09, Vol.2 (9), p.1594-1600

2004

Volltextzugriff (PDF)

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

BMJ, 2008-05, Vol.336 (7655), p.1227-1231

International edition, 2008

Volltextzugriff (PDF)

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls

European journal of epidemiology, 2013-08, Vol.28 (8), p.621-647

2013

Volltextzugriff (PDF)

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

Arteriosclerosis, thrombosis, and vascular biology, 1997-11, Vol.17 (11), p.3071-3078

1997

Volltextzugriff (PDF)

Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial

Arteriosclerosis, thrombosis, and vascular biology, 2003-09, Vol.23 (9), p.1671-1676

2003

Volltextzugriff (PDF)

Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report

Thrombosis and haemostasis, 1999-09, Vol.82 (3), p.1112-1116

1999

Volltextzugriff (PDF)

Associations of Fibrinogen, Factor VII and PAI-1 with Baseline Findings among 10,500 Male Participants in a Prospective Study of Myocardial Infarction: The Prime Study

Thrombosis and haemostasis, 1998, Vol.80 (11), p.749-756

1998

Volltextzugriff (PDF)

β fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction : the ECTIM study

Circulation (New York, N.Y.), 1996-02, Vol.93 (3), p.440-449

1996

Volltextzugriff (PDF)

Safety of combined oral contraceptive pills

The Lancet (British edition), 1996-02, Vol.347 (9000), p.549

1996

Volltextzugriff (PDF)

Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study

Atherosclerosis, 2003, Vol.166 (1), p.103-109

2003

Volltextzugriff (PDF)

The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

Thrombosis and haemostasis, 1995, Vol.74 (3), p.837-841

1995

Volltextzugriff (PDF)

Thrombomodulin promoter mutations, venous thrombosis, and varicose veins

Arteriosclerosis, thrombosis, and vascular biology, 2001-03, Vol.21 (3), p.445-451

2001

Volltextzugriff (PDF)

Assessment of the risk for venous thromboembolism among users of hormone replacement therapy

Drugs & aging, 1999, Vol.14 (1), p.55-61

1999

Volltextzugriff (PDF)

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII

Arteriosclerosis, thrombosis, and vascular biology, 1996-09, Vol.16 (9), p.1170-1176

1996

Volltextzugriff (PDF)

Postmenopausal hormone therapy and cardiovascular disease: An overview of main findings

Maturitas, 2006-07, Vol.54 (4), p.372-379

2006

Volltextzugriff (PDF)

Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population

Arteriosclerosis, thrombosis, and vascular biology, 1997-05, Vol.17 (5), p.851-858

1997

Volltextzugriff (PDF)

Factor VII activation and oral contraceptives

Thrombosis research, 1993-05, Vol.70 (3), p.275-280

1993

Volltextzugriff (PDF)

Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME study

Atherosclerosis, 2001-08, Vol.157 (2), p.431-440

2001

Volltextzugriff (PDF)

Association of Circulating Cellular Adhesion Molecules with Menopausal Status and Hormone Replacement Therapy: Time-Dependent Change in Transdermal, but not Oral Estrogen Users

Thrombosis research, 2001-01, Vol.101 (2), p.35-43

2001

Volltextzugriff (PDF)

Estrogen plus progestin and risk of venous thrombosis

JAMA : the journal of the American Medical Association, 2005-03, Vol.293 (11), p.1322; author reply 1322

Blackwell, Richard E

2005

Volltextzugriff (PDF)

The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women

Thrombosis and haemostasis, 2001-08, Vol.86 (2), p.713-713

2001

Volltextzugriff (PDF)

Menopause-Related Changes in Lipoproteins and Some Other Cardiovascular Risk Factors

International journal of epidemiology, 1990-03, Vol.19 (1), p.42-48

1990

Volltextzugriff (PDF)

Risk of venous thrombosis with hormone replacement therapy

The Lancet (British edition), 1996-12, Vol.348 (9042), p.1668-1668

Scarabin, PY

1996

Volltextzugriff (PDF)

Soluble thrombomodulin as predictor of incident coronary heart disease

The Lancet (British edition), 1999-07, Vol.354 (9176), p.425-426

1999

Volltextzugriff (PDF)

Haemostasis in Relation to Dietary Fat as Estimated by Erythrocyte Fatty Acid Composition: The Prime Study

Thrombosis research, 2001-05, Vol.102 (4), p.285-293

2001

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(46)

Sprache

Englisch
(44)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial

Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial

Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report

Associations of Fibrinogen, Factor VII and PAI-1 with Baseline Findings among 10,500 Male Participants in a Prospective Study of Myocardial Infarction: The Prime Study

β fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction : the ECTIM study

Safety of combined oral contraceptive pills

Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study

The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

Thrombomodulin promoter mutations, venous thrombosis, and varicose veins

Assessment of the risk for venous thromboembolism among users of hormone replacement therapy

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII

Postmenopausal hormone therapy and cardiovascular disease: An overview of main findings

Five frequent polymorphisms of the PAI-1 gene: lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population

Factor VII activation and oral contraceptives

Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME study

Association of Circulating Cellular Adhesion Molecules with Menopausal Status and Hormone Replacement Therapy: Time-Dependent Change in Transdermal, but not Oral Estrogen Users

Estrogen plus progestin and risk of venous thrombosis

The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women

Menopause-Related Changes in Lipoproteins and Some Other Cardiovascular Risk Factors

Risk of venous thrombosis with hormone replacement therapy

Soluble thrombomodulin as predictor of incident coronary heart disease

Haemostasis in Relation to Dietary Fat as Estimated by Erythrocyte Fatty Acid Composition: The Prime Study

Aktive Filter

Suchergebnisse filtern